LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

LLY

1,028

-1.37%↓

JNJ

245.17

-0.42%↓

ABBV

226.93

-0.59%↓

NVS

166.41

-0.16%↓

MRK

122.41

-1.23%↓

Home・Aandelen Lijst・Clover Health Investments Corp

Clover Health Investments Corp

Gesloten

2.09 3.98

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.01

Max

2.1

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -24M
Verkoop	19M 497M
Winstmarge	-4.908
Werknemers	570
EBITDA	-14M -24M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+84.08% upside

Dividenden
By Dow Jones
Volgende Winsten	26 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-868M 1B
Vorige openingsprijs	-1.89
Vorige sluitingsprijs	2.09

Technische score

By Trading Central

Vertrouwen

Very Strong Bullish Evidence

3.4 / 3.77 Steun & Weerstand

Clover Health Investments Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 feb 2026, 23:25 UTC

Populaire aandelen

Stocks to Watch: C3.ai, Salesforce, Pure Storage, Zoom

25 feb 2026, 23:15 UTC

Winsten

Salesforce Sees Stable Growth; CEO Dismisses Talk of AI-Fueled 'SaaS-Pocalypse' -- 2nd Update

25 feb 2026, 23:54 UTC

Marktinformatie

Gold Steady Ahead of U.S.-Iran Talks -- Market Talk

25 feb 2026, 23:47 UTC

Winsten

Ferrovial 4Q Net EUR197M >FER.MC

25 feb 2026, 23:45 UTC

Winsten

Ferrovial 4Q Rev EUR2.72B >FER.MC

25 feb 2026, 23:42 UTC

Winsten

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 4th Update

25 feb 2026, 23:38 UTC

Marktinformatie

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Company's Business Operations Remain Normal >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Gives Update on Investigation by China's State Administration for Market Regulation >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Cannot Predict Status or Results of Investigation, Will Provide Updates on Conclusion >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Increase in FY Profit Primarily Due to Gain From Investments >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Will Continue to Communicate With SAMR on Compliance With Regulatory Requirements >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: SAMR Investigation Related to China's Anti-monopoly Law >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Investigation Ongoing, Company Is Cooperating With SAMR >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com Co-founders Min Fan, Qi Ji Resign From Positions >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com: Fan Resigned as Director and President; Ji Resigned as a Director >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY Rev CNY62.4B, Up 17% >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY Net CNY33.3B Vs. Net CNY17.1B >TCOM

25 feb 2026, 23:25 UTC

Winsten

Trip.com FY EPS CNY47.67 >TCOM

25 feb 2026, 23:06 UTC

Winsten

Correction to Nvidia Fourth Quarter Results Article -- WSJ

25 feb 2026, 23:01 UTC

Winsten

Nvidia Beats Back Bubble Fears With Record $68 Billion Sales in Fourth Quarter -- 3rd Update

25 feb 2026, 23:00 UTC

Marktinformatie

Winsten

Global Equities Roundup: Market Talk

25 feb 2026, 23:00 UTC

Marktinformatie

Winsten

Nvidia: Chinese Competitors Pose Risk to U.S. Dominance in AI -- Market Talk

25 feb 2026, 22:56 UTC

Marktinformatie

Winsten

Nvidia CEO Says Customers Can't Grow Revenue Without Compute -- Market Talk

25 feb 2026, 22:43 UTC

Winsten

Acquisities, Fusies, Overnames

Paramount Streaming Revenue Rises, but TV Segment Faces Headwinds -- WSJ

25 feb 2026, 22:40 UTC

Marktinformatie

Winsten

Nvidia Says Agentic AI Has Reached Inflection Point -- Market Talk

25 feb 2026, 22:40 UTC

Winsten

Karoon Energy Says Search for New CFO Well Advanced

25 feb 2026, 22:39 UTC

Winsten

Karoon Energy Says CFO Ray Church to Leave Company

25 feb 2026, 22:39 UTC

Winsten

Karoon Energy Says On-Market Share Buyback Program Ongoing at Moderated Level

25 feb 2026, 22:38 UTC

Winsten

Karoon Energy Says Guidance for 2026 Key Metrics Unchanged

Peer Vergelijking

Prijswijziging

Clover Health Investments Corp Prognose

Koersdoel

By TipRanks

84.08% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3.7 USD 84.08%

Hoogste 3.7 USD

Laagste 3.7 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Clover Health Investments Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Clover Health Investments Corp - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

3.4 / 3.77Steun & Weerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.